Development and validation of novel inflammatory response-related gene signature to predict prostate cancer recurrence and response to immune checkpoint therapy

ABSTRACT: The aim of this study is to construct an inflammatory response-related genes (IRRGs) signature to monitor biochemical recurrence (BCR) and treatment effects in prostate cancer patients (PCa)

ORGANISM(S): Homo sapiens

PROVIDER: GSE210205 | GEO | 2022/08/04

REPOSITORIES: GEO